SCHEMBL25534616

SCHEMBL25534616

Cc1c(C)n(C)c2c(C)cccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.57
▸ FTO Q9C0B1 1/20 0.57
▸ KDM4E B2RXH2 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ HCRTR1 O43613 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ CYP1A2 P05177 3/20 0.44
▸ CYP2A6 P11509 2/20 0.44
▸ LMNA P02545 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ MAPT P10636 2/20 0.41
▸ CMA1 P23946 1/20 0.39
▸ FABP4 P15090 1/20 0.38
▸ AHR P35869 1/20 0.36
▸ NQO2 P16083 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30583770 1.00 ALKBH5 (0.57) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL14931058 0.81 ALKBH5 (0.72) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL13564048 0.77 ALKBH5 (0.67) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL2311633 0.76 CMA1 (0.50) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL21793464 0.75 ALKBH5 (0.58) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL1094078 0.75 ALKBH5 (0.49) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL482904 0.74 ALDH1A1 (0.47) KDM4EMEN1KMT2AALDH1A1GAA
SCHEMBL21793461 0.72 MAPT (0.63) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL146377 0.72 ALKBH5 (1.00) ALKBH5FTOKDM4EMEN1KMT2A
SCHEMBL28868912 0.72 ALKBH5 (0.46) ALKBH5FTOKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115472241-B Chinese medicine component cluster menstruation determining method based on chemical structure topology index comparison and chromatographic imprinting measurement 湖南中医药大学 2023-07-14 — — CN disclosed
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 — — US disclosed
CN-115472241-A Meridian tropism determination method of traditional Chinese medicine component clusters based on chemical structure topological index comparison and chromatographic blotting measurement and calculation 湖南中医药大学 2022-12-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP2E1 ALKBH5 3970/4885FTO 1544/4885KDM4E 3853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback